Market Research Logo

Calciphylaxis Treatment Market - Size, Share, Trends, and Forecast to 2026

Calciphylaxis Treatment Market - Size, Share, Trends, and Forecast to 2026

Calciphylaxis or calcific uremic arteriolopathy is a syndrome of vascular calcification, thrombosis, and skin necrosis. It mostly occurs in patients with end-stage kidney disease or kidney transplant. Calciphylaxis results in chronic non-healing wounds and is usually fatal. It has a high mortality rate, owing to cardiovascular disease and sepsis caused due to infected skin ulcers. The exact pathogenetic mechanisms of the disease is not known. Most patients with the condition have abnormalities in blood-clotting factors. Multiple interventions are used to treat calciphylaxis, including restoring oxygen and blood flow to the skin, decreasing calcium deposits, and intensive wound treatment.

Market Dynamics

High prevalence of kidney diseases and increasing number of clinical trials in the field of calciphylaxis treatment are major factors expected to drive growth of the calciphylaxis treatment market. According to the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, in 2016, the overall prevalence of chronic kidney diseases in the U.S. was around 14% of total population.

Calciphylaxis has no approved treatment, which has led to increasing number of clinical trials and research, which is expected to fuel growth of the market. For instance, in March 2015, the Multidisciplinary Calciphylaxis Program launched the first randomized trial for treatment of calciphylaxis with research focus on the role of vitamin K in the treatment of the disease.

Lack of an appropriate treatment for calciphylaxis is a major obstacle in the calciphylaxis treatment market growth. However, key players in the market are focused on identifying the root cause of the disease and its associated treatment in order to gain market share. For instance, according to a study published by the American Journal of Nephrology, in June 2018, apixaban, an anticoagulant used to treat venous thromboembolic events, can be a safe and effective alternative to warfarin in patients with End-Stage Renal Disease (ESRD) on dialysis suffering from calciphylaxis.

Key features of the study:

  • This report provides in-depth analysis of the global calciphylaxis treatment market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global calciphylaxis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, 3M, Amgen Inc., BSN Medical, ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris Sanifit S.L.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global calciphylaxis treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for calciphylaxis treatment market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Calciphylaxis Treatment Market, By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • Global Calciphylaxis Treatment Market, By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Global Calciphylaxis Treatment Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Treatment:
  • Drug Therapy
  • Hyperbaric Oxygen Therapy
  • By End User:
  • Hospital and Clinics
  • Homecare
  • Ambulatory Centers
  • Company Profiles
  • 3M*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Amgen Inc.
  • BSN Medical
  • ConvaTec Inc.
  • Medtronic Plc.
  • Smith & Nephew Plc.
  • Laboratoris Sanifit S.L.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Treatment
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Clinical Trials
Epidemiology
PORTER’S Five Forces
4. Global Calciphylaxis Treatment Market, By Treatment, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Drug Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Hyperbaric Oxygen Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Calciphylaxis Treatment Market, By End User, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Homecare
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Ambulatory Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Calciphylaxis Treatment Market, By Region, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2016 – 2026
Regional Trends
North America
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Company Profiles
3M
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Amgen Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
BSN Medical
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
ConvaTec Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Medtronic Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Smith & Nephew Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Laboratoris Sanifit S.L.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
8. Section
References
Research Methodology
About Us and Sales Contact
*Browse 24 market data tables and 21 figures on "Calciphylaxis Treatment Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report